Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. daily Stock Chart
Amgen Inc.
IndexS&P 500 P/E15.40 EPS (ttm)11.00 Insider Own0.10% Shs Outstand726.34M Perf Week-9.99%
Market Cap123.06B Forward P/E12.05 EPS next Y14.06 Insider Trans-1.78% Shs Float719.39M Perf Month-7.14%
Income8.08B PEG3.67 EPS next Q3.22 Inst Own82.40% Short Float1.44% Perf Quarter-4.34%
Sales22.85B P/S5.39 EPS this Y7.30% Inst Trans-0.02% Short Ratio2.04 Perf Half Y-9.22%
Book/sh34.82 P/B4.87 EPS next Y4.71% ROA2.50% Target Price195.61 Perf Year2.04%
Cash/sh57.38 P/C2.95 EPS next 5Y4.20% ROE6.60% 52W Range152.16 - 201.23 Perf YTD-2.57%
Dividend5.28 P/FCF17.22 EPS past 5Y14.40% ROI14.00% 52W High-15.80% Beta1.34
Dividend %3.12% Quick Ratio5.20 Sales past 5Y5.80% Gross Margin82.20% 52W Low11.35% ATR4.42
Employees20800 Current Ratio5.50 Sales Q/Q-2.70% Oper. Margin43.60% RSI (14)26.90 Volatility3.11% 2.30%
OptionableYes Debt/Eq1.40 EPS Q/Q-2.90% Profit Margin8.70% Rel Volume0.88 Prev Close176.08
ShortableYes LT Debt/Eq1.35 EarningsFeb 01 AMC Payout174.60% Avg Volume5.07M Price169.43
Recom2.40 SMA20-9.13% SMA50-8.51% SMA200-5.01% Volume4,476,204 Change-3.78%
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Dec-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-23-18 08:50AM  The Zacks Analyst Blog Highlights: Amgen, FedEx, Thermo Fisher, Sherwin-Williams and Ameriprise Zacks
08:44AM  Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes PR Newswire
08:41AM  Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin®) For The Treatment Of Three Types Of Cancer PR Newswire
Mar-22-18 04:26PM  Top Stock Reports for Amgen, FedEx & Thermo Fisher Zacks
11:46AM  Biotech Winners And Losers From Congress' Latest Funding Bill Benzinga
Mar-21-18 04:27PM  Drug companies are beginning to wake up to this new risk factor MarketWatch
06:08AM  Better Buy: Amgen Inc. vs. Gilead Sciences, Inc. Motley Fool
Mar-20-18 08:12AM  The Medicines Company CEO, Dr. Clive Meanwell, On The Impact Of ODYSSEY OUTCOMES For Heart Patients Forbes
Mar-19-18 04:31PM  Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger Investor's Business Daily
04:16PM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Mar-16-18 12:23PM  Why A Biopharma Buying Spree May Target AstraZeneca, Bristol Investor's Business Daily
08:18AM  5 Must-See Quotes From AbbVie's Management Motley Fool
Mar-15-18 01:34PM  Does Amgen Incs (NASDAQ:AMGN) Past Performance Indicate A Weaker Future? Simply Wall St.
Mar-14-18 09:50AM  Is Amgen Inc. (AMGN) a Great Stock for Value Investors? Zacks
Mar-13-18 02:35PM  Biogens Bargain Price May Spur a 14% Stock Gain Investopedia
11:40AM  Amgen Stock Split History Motley Fool
Mar-12-18 09:16PM  Regeneron Takes Aim at Amgen and Esperion Therapeutics Motley Fool
04:53PM  How A Strong Trial From Regeneron Pharma Could Help These Rivals Investor's Business Daily
02:12PM  Regeneron Pharma Turnaround Gains Steam Investopedia
01:56PM  Sanofi and Regeneron's Price Gamble Is Worth It Bloomberg
01:38PM  Drugmakers Try a Rare Tactic to Boost Sales: Cutting the Price Bloomberg
11:27AM  In The War Against High Drug Prices, Some Patients Are Collateral Damage Forbes
10:33AM  Good Reasons to Stick With Biotech ETFs ETF Trends
09:53AM  Regeneron CEO: Were trying to change the paradigm on dru... CNBC Videos
08:37AM  In Cholesterol Drug Battle, Sanofi/Regeneron Jolt Prospects Of The Medicines Company And Esperion Forbes
06:16AM  New cholesterol data shows drug reduces cardiac events CNBC Videos
12:29AM  Regeneron and Sanofi Plan to Cut Cholesterol Drug Price in Exchange for Wider Coverage The Wall Street Journal
Mar-11-18 04:58PM  The Week Ahead In Biotech: Earnings, PDUFA Dates And More Benzinga
Mar-10-18 09:37AM  Regeneron/Sanofi offer new Praluent pricing to break reimbursement logjam Reuters
09:02AM  Opposite Day: Drug May Save Lives, So Drugmakers Offer To Cut Price Forbes
09:00AM  Regeneron and Sanofi Plan to Cut Cholesterol Drug Price The Wall Street Journal
09:00AM  The ODYSSEY Trial Ends Well -- But Will It Be Enough? Forbes
Mar-09-18 04:20PM  How This Small-Cap Biotech Plans To Chip Away At Amgen's Biggest Drugs Investor's Business Daily
01:18PM  Pharma Stocks Weighed Down by Competition, Generic Pressure Zacks
11:49AM  Why Coherus Biosciences Is Skyrocketing Today Motley Fool
09:00AM  New Analyses Show Payer Utilization Management Criteria Deny Access To PCSK9 Inhibitors For Patients At The Highest Risk For Subsequent Cardiovascular Events PR Newswire
08:30AM  Todays Research Reports on Trending Tickers: AbbVie Inc. and Amgen Inc. ACCESSWIRE
Mar-08-18 11:31AM  Amgen Inc (NASDAQ:AMGN): What Are The Future Prospects? Simply Wall St.
09:00AM  Amgen Announces Final Results Of Tender Offer PR Newswire
Mar-07-18 04:41PM  Why Regeneron Pharma Won't Unseat Amgen In Cholesterol Drugs Investor's Business Daily
04:15PM  Amgen Announces 2018 Second Quarter Dividend PR Newswire
04:00PM  Pharmaceutical Industry Outlook - March 2018 Zacks
04:00PM  Amgen To Present At the Cowen and Company 38th Annual Health Care Conference PR Newswire
07:14AM  Jim Cramer Gives His Opinion On Lockheed Martin, DowDuPont And More Benzinga
Mar-06-18 09:34PM  3 Top Biotech Stocks to Buy in March Motley Fool
09:00AM  Amgen Announces Preliminary Results Of Tender Offer PR Newswire
Mar-01-18 09:40AM  Amgen (AMGN) Gets CHMP Nod to Expand EU Label of Neulasta Zacks
01:04AM  Biocartis Group NV: BIOCARTIS ANNOUNCES 2017 RESULTS AND 2018 OUTLOOK GlobeNewswire
Feb-28-18 01:26PM  Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo Zacks
10:08AM  Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Benzinga
Feb-27-18 09:00AM  Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta® (pegfilgrastim) PR Newswire
Feb-26-18 04:00PM  Amgen To Present New Data From Repatha® (evolocumab) Clinical Trials At ACC.18 PR Newswire
Feb-23-18 08:20AM  Amgen Receives Positive Opinion Expanding Use Of XGEVA® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe PR Newswire
Feb-21-18 08:32AM  Is Amgen Inc. a Buy? Motley Fool
08:07AM  The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex Zacks
05:23AM  Merck to buy Australian viral immuno-oncology firm for $394 million Reuters
Feb-20-18 04:58PM  Top Analyst Report for Amgen, TOTAL S.A. & Marriott Zacks
02:40PM  Minority Report
02:00PM  10 Stocks Poised To Outperform On Record Buybacks Investopedia
01:25PM  Healthcare costs to put more stress on the family budget Yahoo Finance Video
08:30AM  New Research Coverage Highlights SunCoke Energy Partners, Carrols Restaurant Group, First Financial, Emerson Electric, Puma Biotechnology, and Amgen Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
12:40AM  [$$] US companies might be liquidating their offshore bond hoards Financial Times
Feb-15-18 03:21PM  The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs Forbes
07:34AM  3 Tough Questions for Amgen Motley Fool
Feb-14-18 04:00PM  Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab) PR Newswire
Feb-12-18 02:19PM  First look: Inside Amgens "next-generation" workspace in Tampa American City Business Journals
08:30AM  Todays Research Reports on Trending Tickers: Amgen and Celgene ACCESSWIRE
Feb-11-18 09:37AM  Better Buy: Amgen Inc. vs. Celgene Motley Fool
Feb-10-18 02:33PM  3 ETFs to Watch on Biotech Earnings Zacks
12:35PM  Interested In Amgen Inc (NASDAQ:AMGN)s Upcoming $1.32 Dividend? You Have 3 Days Left Simply Wall St.
Feb-09-18 06:04AM  Forget Amgen -- Cara Therapeutics, Inc. Is a Better Growth Stock Motley Fool
Feb-08-18 06:44PM  Results From Phase 3 XGEVA® (Denosumab) Study In Patients With Multiple Myeloma Published In The Lancet Oncology PR Newswire
04:00PM  Amgen To Present At The 7th Annual Leerink Partners Global Healthcare Conference PR Newswire
Feb-07-18 02:15PM  Democrats slam Republican tax cut for $97 billion wave in corporate share buybacks CNBC
Feb-05-18 01:37PM  Cramer vs. Chaikin: Amgen -- Be Careful of This Stock -6.56%
Feb-03-18 10:33AM  Amgen Q4 Earnings Results: 2 Things to Hate and 2 Things to Like Motley Fool
Feb-02-18 08:58PM  Dow Gets Crushed as Bad Week Gets Worse
04:33PM  Apple and Alphabet skid while Amgen and Edwards jump Associated Press
04:30PM  Biotech stocks hold up amid market sell-off CNBC Videos
02:12PM  Investors love Amgens buybacks if not its growth MarketWatch
11:56AM  Pharma Investors Suffer From Tax Myopia Bloomberg
11:32AM  Amgen Posts Fourth Quarter Numbers
10:27AM  Amgen Inc. -- Moody's affirms Amgen at Baa1; outlook stable Moody's
10:00AM  Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft Zacks
09:17AM  Stocks to Watch: Apple, Amazon, Alphabet, Visa, Sprint, Exxon, Mattel, Merck, Viacom The Wall Street Journal
Feb-01-18 05:26PM  [$$] Amgen Plans New U.S. Plant After Tax Changes The Wall Street Journal
05:04PM  Amgen Topples After Fourth-Quarter Sales, Earnings Lag Investor's Business Daily
04:24PM  Amgen shares drop 4% after Q4 profit, revenue misses MarketWatch
04:15PM  Amgen quarterly profit misses, 2018 EPS outlook ahead of Street view Reuters
04:13PM  Amgen reports 4Q loss Associated Press
04:01PM  Amgen Reports Fourth Quarter And Full Year 2017 Financial Results PR Newswire
04:00PM  Amgen shares sink after earnings miss CNBC Videos
08:40AM  Amgen Q4 Earnings Preview Benzinga
Jan-31-18 09:44AM  Amgen Gets CHMP Nod to Add ENDEAVOR Data on Kyprolis Label Zacks
08:36AM  Why Earnings Season Could Be Great for Amgen (AMGN) Zacks
Jan-30-18 09:00AM  Amgen Receives CHMP Positive Opinion To Add Updated Overall Survival Data To KYPROLIS® (carfilzomib) Label PR Newswire
Jan-29-18 06:45PM  Cramer's charts forecast further gains for health care gi... CNBC Videos
04:00PM  Amgen Announces Webcast of 2017 Fourth Quarter and Full Year Financial Results PR Newswire
09:55AM  Will Amgen (AMGN) Benefit From Growth Drugs in Q4 Earnings? Zacks
Jan-28-18 05:31PM  Benzinga's Weekly Bulls & Bears: Amazon, Apple, GE, Twitter And More Benzinga
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Aimovig for the prevention of migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor for the treatment of multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound. The company's marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harper Sean EEVP, Research & DevelopmentMar 16Sale189.751,525289,36965,682Mar 19 08:52 PM
Harper Sean EEVP, Research & DevelopmentFeb 14Sale174.181,525265,62552,089Feb 15 08:57 PM
Harper Sean EEVP, Research & DevelopmentJan 16Sale185.621,525283,07154,673Jan 17 08:19 PM
Harper Sean EEVP, Research & DevelopmentDec 12Sale176.831,525269,66656,106Dec 12 08:24 PM
Harper Sean EEVP, Research & DevelopmentNov 13Sale171.581,525261,66057,631Nov 14 07:27 PM
de Carbonnel FrancoisDirectorNov 08Sale173.614,000694,42215,528Nov 08 05:39 PM
Harper Sean EEVP, Research & DevelopmentOct 09Sale185.951,525283,57459,156Oct 10 08:29 PM
BALTIMORE DAVIDDirectorMay 31Sale153.933,700569,54131,159Jun 02 07:21 PM
Patton Cynthia MSVP & CCOMay 24Sale154.402,922451,16421,292May 24 07:35 PM